Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7682609 Protein formulation

Patent 7682609 was granted and assigned to Genentech on March, 2010 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Genentech
Genentech
0
Date Filed
May 26, 2006
0
Date of Patent
March 23, 2010
0
Patent Application Number
11441994
0
Patent Citations Received
‌
US Patent 11655305 Treatment of metastatic breast cancer
0
‌
US Patent 12128103 Adjuvant treatment of HER2-positive breast cancer
0
‌
US Patent 12110341 Composition comprising antibody that binds to domain II of HER2 and acidic variants thereof
0
‌
US Patent 11654105 Subcutaneous HER2 antibody formulations
0
‌
US Patent 11992529 Adjuvant treatment of HER2-positive breast cancer
0
Patent Inventor Names
Chung C. Hsu
0
David E. Overcashier
0
James Andya
0
Janet Yu-Feng Yang
0
Jeffrey L. Cleland
0
Steven J. Shire
0
Sylvia Sau-Yan Wu
0
Xanthe M. Lam
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
7682609
0
Patent Primary Examiner
‌
Christopher H. Yaen
0

Find more entities like US Patent 7682609 Protein formulation

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.